Rhythm Pharmaceuticals, Inc.
RYTM
$50.97
$0.731.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.29M | -43.68M | -32.26M | -141.37M | -41.63M |
| Total Depreciation and Amortization | 383.00K | 385.00K | 390.00K | 405.00K | 417.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.86M | 13.38M | 4.94M | 102.41M | 2.92M |
| Change in Net Operating Assets | 10.21M | 4.70M | -2.15M | -2.19M | 8.91M |
| Cash from Operations | -18.85M | -25.22M | -29.08M | -40.74M | -29.38M |
| Capital Expenditure | -- | -- | -- | -- | 1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.16M | -90.82M | -8.56M | 30.05M | 22.64M |
| Cash from Investing | 21.16M | -90.82M | -8.56M | 30.05M | 22.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 42.14M | 5.83M | 1.40M | 7.03M | 5.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 138.85M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.81M | -3.34M | 5.93M | -2.78M | -2.57M |
| Cash from Financing | 38.33M | 2.49M | 146.18M | 4.24M | 2.42M |
| Foreign Exchange rate Adjustments | 977.00K | -603.00K | -301.00K | -71.00K | -192.00K |
| Miscellaneous Cash Flow Adjustments | 1.00K | -1.00K | -- | -- | -- |
| Net Change in Cash | 41.62M | -114.15M | 108.24M | -6.52M | -4.51M |
